Why do patients with obesity discontinue glucagon-like peptide 1 analogues? Almohaileb FI, le Roux CW, Crotty M. Why do patients with obesity discontinue glucagon-like peptide 1 analogues? Diabetes Obes Metab
Global barriers to decision makers for prioritizing interventions for obesity Ehlers LH, Reinstrup NW, Olesen RH, Holm JC, McEwan P, Le Roux CW. Global barriers to decision makers for prioritizing interventions for obesity International Journal of Obesity
A Managed Access Protocol for Liraglutide for Weight Management: A Retrospective, Observational Study in Ireland Barrett R, Smith A, Gorry C, Doran S, Barry M, McCullagh L. A Managed Access Protocol for Liraglutide for Weight Management: A Retrospective, Observational Study in Ireland The Journal of the International Society for Pharmaeconomics and Outcomes Research
Weight Loss Maintenance After Financial Incentives End-Reply Hoddinott P, Dombrowski SU, Kee F. Weight Loss Maintenance After Financial Incentives End-Reply JAMA
Pediatric Weight Management Through mHealth Compared to Face-to-Face Care: Cost Analysis of a Randomized Control Trial L. Tully; J. Sorensen; G. O'Malley Pediatric Weight Management Through mHealth Compared to Face-to-Face Care: Cost Analysis of a Randomized Control Trial JMIR Mhealth Uhealth
Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses E. R. McGlone; I. Carey; V. Veličković; P. Chana; K. Mahawar; R. L. Batterham; J. Hopkins; P. Walton; R. Kinsman; J. Byrne; S. Somers; D. Kerrigan; V. Menon; C. Borg; A. Ahmed; B. Sgromo; C. Cheruvu; G. Bano; C. Leonard; H. Thom; C. W. le Roux; M. Reddy; Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses PLoS Med Insulin Resistance & Diabetes
Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial D. Papamargaritis; W. Al-Najim; J. Lim; J. Crane; M. Lean; C. le Roux; B. McGowan; D. O'Shea; D. Webb; J. Wilding; M. J. Davies Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial BMJ Open Insulin Resistance & Diabetes
Cost-effectiveness of a mobile health-supported lifestyle intervention for pregnant women with an elevated body mass index E. J. O' Sullivan; S. Rokicki; M. Kennelly; K. Ainscough; F. M. McAuliffe Cost-effectiveness of a mobile health-supported lifestyle intervention for pregnant women with an elevated body mass index International Journal of Obesity
Hospital Service Use Among Children With Obesity in Ireland: A Micro-costing Study L. Tully; J. Sorensen; G. O'Malley Hospital Service Use Among Children With Obesity in Ireland: A Micro-costing Study Child Care in Practice
Relationship between monetary delay discounting and obesity: a systematic review and meta-regression J. Tang; O. J. Chrzanowski-Smith; G. Hutchinson; F. Kee; R. F. Hunter Relationship between monetary delay discounting and obesity: a systematic review and meta-regression Int J Obes (Lond)